31
Samuel K Yue: Method of treating myofascial pain syndrome with relaxin. January 26, 1999: US05863552 (37 worldwide citation)

A method of treating involuntary muscle dysfunctions includes administering a therapeuticaly effective amount of relaxin to a patient. Involuntary muscle dysfunctions amenable to treatment with relaxin include fibromyalgia, myofascial pain syndrome, chronic fatigue syndrome, dystonia, pelvic floor d ...


32
Ernst Glen, Phillips Eifion, Schmiesing Richard: Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists.. Astrazeneca, Ernst Glen, Phillips Eifion, Schmiesing Richard, ASTRAZENECA, February 26, 2004: WO/2004/016616 (37 worldwide citation)

Nicotinic acetylcholine receptor agonists of formula I wherein a, b, c, D and R are as defined in the specification, enantiomers, pharmaceutically- acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same in the treatment or prophylaxis of psychotic ...


33
Henry C Lin, Mark Pimentel: Methods of diagnosing small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions. Cedars Sinai Medical Center, Seth D Levy, Davis Wright Tremaine, June 15, 2010: US07736622 (36 worldwide citation)

Disclosed is a method of treating small intestinal bacterial overgrowth (SIBO) or a SIBO-caused condition in a human subject. SIBO-caused conditions include irritable bowel syndrome, fibromyalgia, chronic pelvic pain syndrome, chronic fatigue syndrome, depression, impaired mentation, impaired memory ...


34
Stephen C Perry: Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome. Malin Haley & DiMaggio P A, March 20, 2001: US06203797 (36 worldwide citation)

A dietary supplement for use as a probiotic and for alleviating symptoms of irritable bowel syndrome, comprising freeze-dried aloe, fructo-oligosaccharides, and dahlia inulin juice mixture and optionally vitamin B6 (pyridoxine) manganese and L-glutamine. An additional alternate embodiments specifica ...


35
Iguchi Satoru, Katsu Yasuhiro, Sone Hiroki, Uchida Chikara, Kojima Takashi: Benzimidazolone compounds having 5-ht4 receptor agonistic activity. Pfizer Japan, Pfizer, Iguchi Satoru, Katsu Yasuhiro, Sone Hiroki, Uchida Chikara, Kojima Takashi, FULLER Grover F Jr, March 10, 2005: WO/2005/021539 (36 worldwide citation)

This invention provides a compound of the formula (I) or a pharmaceutically acceptable salt thereof, and compositions containing such compounds and the use of such compounds for the manufacture of medicament for gastroesophageal reflux disease, gastrointestinal disease, gastric motility disorder, no ...


36
Peter E Cross, Alexander R MacKenzie: Pyrrolidine derivatives. Pfizer, Peter C Richardson, Paul H Ginsburg, Seymore G Bekelnitzky, March 17, 1992: US05096890 (35 worldwide citation)

Compounds of the formula ##STR1## wherein R, Y and R.sup.1 are as defined in the specification. These compounds are muscarinic receptor antagonists which are selective for smooth muscle muscarinic sites over cardiac muscarinic sites, and are useful in the treatment of diseases associated with altere ...


37
Henry C Lin, Mark Pimentel: Methods of treating diarrhea caused by small intestinal bacterial overgrowth. Cedars Sinai Medical Center, Seth D Levy, Davis Wright Tremaine, May 3, 2011: US07935799 (34 worldwide citation)

Disclosed is a method of diagnosing irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, depression, attention deficit/hyperactivity disorder, autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, or Crohn's disease, which involves detecting the presence of s ...


38
Samuel K Yue: Method of treating fibromyalgia with relaxin. Kinney & Lange P A, January 13, 1998: US05707642 (34 worldwide citation)

A method of treating involuntary muscle dysfunctions includes administering a therapeuticaly effective amount of relaxin to a patient. Involuntary muscle dysfunctions amenable to treatment with relaxin include fibromyalgia, myofascial pain syndrome, chronic fatigue syndrome, dystonia, pelvic floor d ...


39
Daniel P Becker, Daniel L Flynn, Alan E Moormann, Roger Nosal, Clara I Villamil: Imidazopyridines as serotonergic 5-HT.sub.3 antagonists. G D Searle & Co, Cynthia S Kovacevic, Roger A Williams, November 9, 1993: US05260303 (33 worldwide citation)

The imidazopyridines compounds of the present invention are serotonergic 5-HT.sub.3 antagonists. As such they are useful for the treatment of humans and animals wherein antagonism of 5-HT.sub.3 receptors is beneficial. Therapy is indicated for, but not limited to, the treatment of anxiety, psychoses ...


40
Cari Loder, David F Horrobin: Treatment of fatigue, head injury and stroke. Laxdale, Foley & Lardner, August 27, 2002: US06441038 (33 worldwide citation)

A method of treatment of disorders of neurological origin and drug formulations for use in the method are disclosed. These conditions comprise fatigue and associated syndromes of pain, weakness and depressed mood which are associated with chronic fatigue syndrome, brain injury and stroke, stress, fi ...